| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.06 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.07 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.085 | 0.07 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.08 |